S

Southwest Houston Research, Ltd. | Houston, TX

Research site

Location

10850 South Wilcrest Drive, Suite 170-A, Houston, Texas, United States of America

Site insights

Top conditions

Top treatments

Semaglutide

Zirconium Silicate

Bardoxolone Methyl

Clazakizumab

ONO-5129

VX-147

Calcifediol

CTAP101

Iron

PF-04634817

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

marializa bernardo

Verified by this site

Active trials

3 of 29 total trials

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a two-part, phase 2b and phase 3 combined prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study.Part 1...

Enrolling

End Stage Kidney Disease

Drug: Placebo

Drug: CSL300

Phase 2/3 Adaptive Study of VX-147 in Adult and Pediatric Participants With APOL1-Mediated Proteinuric Kidney Disease (AMPLITUDE)

The purpose of this study is to evaluate the efficacy, safety, tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants...

Enrolling

Proteinuric Kidney Disease

Drug: VX-147

Drug: Placebo

REDEFINE 3: A Research Study to See the Effects of CagriSema in People Living With Diseases in the Heart and Blood Vessels

This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardiovascular...

Active, not recruiting

Cardiovascular Disease

Drug: Cagrilintide

Drug: Semaglutide